Back to top

Amphastar reports Q2 adjusted EPS 91c, consensus 61c

Reports Q2 revenue $183.9M, consensus $179.92M. “Our Q2 results reflect the continued execution of our long-term strategy to build a more diversifi...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Amphastar Pharmaceuticals, Inc. (AMPH)